| Drug Name | Myozyme (alglucosidase alfa) |
|---|---|
| Drug Class | |
| Risk minimization type |
Healthcare provider guide
|
| Specialty (Theraputic area) | |
| Risk |
Guidance for health care professionals on risks associated with Myozyme® administration, clinical risk management and immunology testing |
| Health care provider guide |
|